I think FIL know (as we all do) that Resapp is a prime takeover target. Having so much invested will strengthen their hand when an offer is made. The interesting scenario is whether the offer comes after latest results but before FDA approval, or after FDA approval. Of course the price would skyrocket after FDA so it may come pre FDA...what price? I'd be happy with $5.00ps.
- Forums
- ASX - By Stock
- RAP
- RAP - The Main Game
RAP - The Main Game, page-1123
-
-
- There are more pages in this discussion • 482 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online